Back to results
US 2021/0332015 A1Published application
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
AssigneeZ Factor Limited
InventorsNigel RAMSDEN, David John FOX, James Andrew HUNTINGTON
Life of this patent
Estimating the term…
Abstract
The invention relates to oxopyrimidinyl-methyl-benzamide derivatives, for example in a pharmaceutically acceptable salt form or crystal form, pharmaceutical compositions comprising the derivatives, and their medical use, in particular for use in the treatment of α1-antitrypsin deficiency (A1AD or AATD).
Claims10
1-13. (canceled)
A compound represented by the structure of:
- or a pharmaceutically acceptable salt of any one thereof.
Dependencies are inferred from the claim text.